No headlines found.
Owens & Minor, Inc. Completes Sale of Products & Healthcare Services Business to Platinum Equity
Business Wire (Wed, 31-Dec 4:05 PM ET)
Owens & Minor Announces Corporate Name Change to Accendra Health, Inc.
Business Wire (Thu, 18-Dec 4:05 PM ET)
Owens & Minor to Present at Upcoming Investor Conferences on December 2, 2025
Business Wire (Tue, 2-Dec 7:00 AM ET)
Owens & Minor Reports Third Quarter 2025 Financial Results
Business Wire (Thu, 30-Oct 4:05 PM ET)
Business Wire (Thu, 16-Oct 6:30 AM ET)
PLATINUM EQUITY TO ACQUIRE PRODUCTS & HEALTHCARE SERVICES BUSINESS FROM OWENS & MINOR
PRNewswire (Tue, 7-Oct 4:22 PM ET)
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
Owens & Minor trades on the NYSE stock market under the symbol OMI.
As of January 5, 2026, OMI stock price was flat at $2.80 with million shares trading.
OMI has a beta of 0.91, meaning it tends to be less sensitive to market movements. OMI has a correlation of 0.03 to the broad based SPY ETF.
OMI has a market cap of $216.57 million. This is considered a Small Cap stock.
Last quarter Owens & Minor reported $697 million in Revenue and $.25 earnings per share. This fell short of revenue expectation by $-6 million and exceeded earnings estimates by $.02.
In the last 3 years, OMI traded as high as $28.35 and as low as $2.38.
The top ETF exchange traded funds that OMI belongs to (by Net Assets): VTI, VXF, VFVA, VTWO, VHT.
OMI has underperformed the market in the last year with a price return of -78.2% while the SPY ETF gained +18.9%. OMI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -42.1% and -1.4%, respectively, while the SPY returned +3.0% and +1.0%, respectively.
OMI support price is $2.67 and resistance is $2.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OMI shares will trade within this expected range on the day.
